136 related articles for article (PubMed ID: 23094226)
1. Risk stratification for serosal invasion using preoperative predictors in patients with advanced gastric cancer.
Park SS; Min JS; Lee KJ; Jin SH; Park S; Bang HY; Yu HJ; Lee JI
J Gastric Cancer; 2012 Sep; 12(3):149-55. PubMed ID: 23094226
[TBL] [Abstract][Full Text] [Related]
2. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
Wang PL; Huang JY; Zhu Z; Gong BC; Huang HW; Duan SJ; Xu HM; Liu FN
Eur J Surg Oncol; 2018 May; 44(5):600-606. PubMed ID: 29454557
[TBL] [Abstract][Full Text] [Related]
3. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
4. Borrmann Type 1 Cancer is Associated with a High Recurrence Rate in Locally Advanced Gastric Cancer.
Kim JH; Lee HH; Seo HS; Jung YJ; Park CH
Ann Surg Oncol; 2018 Jul; 25(7):2044-2052. PubMed ID: 29752601
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of macroscopic intraoperative diagnosis of serosal invasion and risk of over- and underestimation in gastric carcinoma.
Jeong O; Ryu SY; Jeong MR; Sun JW; Park YK
World J Surg; 2011 Oct; 35(10):2252-8. PubMed ID: 21850605
[TBL] [Abstract][Full Text] [Related]
6. Macroscopic intraoperative diagnosis of serosal invasion and clinical outcome of gastric cancer: risk of underestimation.
Ichiyoshi Y; Maehara Y; Tomisaki S; Oiwa H; Sakaguchi Y; Ohno S; Sugimachi K
J Surg Oncol; 1995 Aug; 59(4):255-60. PubMed ID: 7630174
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
8. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China.
Song XH; Zhang WH; Kai-Liu ; Chen XL; Zhao LY; Chen XZ; Kun-Yang ; Zhou ZG; Hu JK
World J Surg Oncol; 2020 Aug; 18(1):204. PubMed ID: 32792016
[TBL] [Abstract][Full Text] [Related]
10. [Correlations between invasion of gastric cancer to serosal layer and other relevant factors].
Wang H; Hui Z; Li L
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):281-3. PubMed ID: 11776816
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer.
Zhai Z; Zhu ZY; Zhang Y; Yin X; Han BL; Gao JL; Lou SH; Fang TY; Wang YM; Li CF; Yu XF; Ma Y; Xue YW
World J Gastrointest Oncol; 2020 Sep; 12(9):992-1004. PubMed ID: 33005293
[TBL] [Abstract][Full Text] [Related]
12. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of patients with Borrmann type IV gastric carcinoma.
Kim DY; Kim HR; Kim YJ; Kim S
ANZ J Surg; 2002 Oct; 72(10):739-42. PubMed ID: 12534387
[TBL] [Abstract][Full Text] [Related]
15. Consideration of clinicopathologic features improves patient stratification for multimodal treatment of gastric cancer.
Cho I; Kwon IG; Guner A; Son T; Kim HI; Kang DR; Noh SH; Lim JS; Hyung WJ
Oncotarget; 2017 Oct; 8(45):79594-79603. PubMed ID: 29108339
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.
Huang B; Sun Z; Wang Z; Lu C; Xing C; Zhao B; Xu H
BMC Cancer; 2013 Feb; 13():57. PubMed ID: 23379700
[TBL] [Abstract][Full Text] [Related]
17. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
[TBL] [Abstract][Full Text] [Related]
18. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
19. Laparoscopy-assisted versus open D2 radical gastrectomy for advanced gastric cancer without serosal invasion: a case control study.
Chen QY; Huang CM; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J
World J Surg Oncol; 2012 Nov; 10():248. PubMed ID: 23158876
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and prognosis of Borrmann type IV gastric cancer.
Zhu YL; Yang L; Sui ZQ; Liu L; Du JF
J BUON; 2016; 21(6):1471-1475. PubMed ID: 28039710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
